Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Article from Phase II study in prostate cancer now published in the March issue of Journal of Nuclear Medicine and highlighted as best clinical investigation article
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Annual Report for the fiscal year 2020
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Year-end report October – December 2020
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: US patent application 14/399,820 relating to uTREAT[®] is accepted for grant
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Japanese patent application 2019-005811 is accepted for grant
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Financial Calendar 2021
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Interim report January – September 2020
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Interim report January – September 2020